News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
459 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (17894)
Month
January (4450)
February (4428)
March (5683)
April (4545)
May (5703)
June (4805)
July (3912)
August (4762)
September (4260)
October (3860)
November (4837)
December (2683)
Day
1 (296)
2 (275)
3 (459)
4 (106)
5 (7)
6 (13)
7 (344)
8 (327)
9 (280)
10 (467)
11 (105)
12 (3)
13 (17)
14 (341)
15 (218)
16 (179)
17 (201)
18 (74)
19 (1)
20 (3)
21 (196)
22 (215)
23 (93)
24 (12)
25 (23)
27 (11)
28 (200)
29 (193)
30 (178)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
27
28
29
30
Business
Calyxt Reports Third Quarter 2022 Financial Results and Provides Corporate Update
Calyxt, Inc. (Nasdaq: CLXT), a plant-based synthetic biology company, today announced operating and financial results for its third quarter ended September 30, 2022.
November 3, 2022
·
28 min read
Business
AMGEN REPORTS THIRD QUARTER 2022 FINANCIAL RESULTS
Amgen (NASDAQ:AMGN) today announced financial results for the third quarter of 2022.
November 3, 2022
·
43 min read
Business
Syndax Pharmaceuticals Reports Third Quarter 2022 Financial Results and Provides Clinical and Business Update
Syndax Pharmaceuticals, Inc. (Nasdaq: SNDX), a clinical-stage biopharmaceutical company developing an innovative pipeline of cancer therapies, today reported its financial results and provided a business update for the third quarter ended September 30, 2022.
November 3, 2022
·
12 min read
BioCapital
ASH 2022 | Ascentage Pharma to Present Data of Olverembatinib (HQP1351) in Three Oral Reports, Including the First Dataset from the First US Study, at the ASH Annual Meeting
Ascentage Pharma announced that the updated results from three studies of the company’s novel drug candidate, olverembatinib, have been selected for oral presentations at the 64th American Society of Hematology Annual Meeting.
November 3, 2022
·
18 min read
Biotech Beach
Inari Medical to Participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum
Inari Medical, Inc. announced that its management team will participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum at the Westin NY Grand Central Hotel in New York on Thursday, November 17, 2022.
November 3, 2022
·
1 min read
Business
Galapagos announces strategy to accelerate innovation and reports strong third quarter 2022 results
Galapagos NV announced its strategy for accelerated growth and value creation, its financial results for the first nine months of 2022, and theoutlook for the remainder of 2022.
November 3, 2022
·
24 min read
Business
Theriva Biologics to Host Conference Call and Webcast to Discuss Third Quarter 2022 Operational Highlights and Financial Results
Theriva Biologics announced that it plans to host a conference call on Thursday, November 10, 2022, at 8:30 a.m. ET to discuss its financial results for the quarter ended September 30, 2022 and provide a corporate update.
November 3, 2022
·
2 min read
Business
Fresh Tracks Therapeutics to Report Third Quarter 2022 Financial Results and Provide a Corporate Update on November 10, 2022
Fresh Tracks Therapeutics, Inc. announced that it will report its third quarter financial results on Thursday, November 10th.
November 3, 2022
·
2 min read
Business
Oncternal Therapeutics Provides Business Update and Announces Third Quarter 2022 Financial Results
Oncternal Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on the development of novel oncology therapies, provided a business update and reported financial results for the third quarter of 2022.
November 3, 2022
·
9 min read
Business
Adaptive Biotechnologies Reports Third Quarter 2022 Financial Results
Adaptive Biotechnologies Corporation reported financial results for the quarter ended September 30, 2022.
November 3, 2022
·
11 min read
Previous
15 of 46
Next